Pathogenesis of HIV-associated depression: contributing factors and underlying mechanisms
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Cumulative evidence indicates that compared to HIV negative individuals, people living with HIV (PLWH) have a higher likelihood of developing depression, anxiety, and cognitive disorders. Depression, which is known to be a persistent and overwhelming feeling of sadness accompanied by a loss of interest in usual activities, is one of the most common mental illnesses encountered during HIV infection. Experts believe that several factors such as neuroinflammation, life stressors, lack of sleep, poor nutritional state, opportunistic infections and comorbidities, and HIV medications are contributing factors favoring the development of depression in PLWH. However, the fundamental mechanisms which underlie the involvement of these factors in the emergence of depression in the context of HIV remain poorly explored. Past researches describing the role of one or two of the preceding factors do exist; however, very few articles tackle this important topic while considering the several different putative causative factors comprehensively in the particular context of HIV infection. Herein, we elaborate on the factors currently understood to be responsible for the development of depression, and discuss the particular fundamental mechanisms whereby each factor may result in the outcome of depression. We believe that the understanding of these factors and of their underlying mechanisms is essential for the development of future therapeutic interventions to alleviate the burden of depression commonly seen in PLWH, and therefore facilitate the development of strategies to improve their overall quality of life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In HIV infection, sustained microglial activation driven by viral proteins and CCR2-mediated monocyte trafficking, combined with IDO1-induced kynurenine pathway dysregulation and elevated CSF IL-6 and TNF-alpha, produces depressive symptoms in 30–50% of people living with HIV independent of viral load or antiretroviral status”
From Neuroinflammation and depression: immune-brain interface mechanisms, biomarker stratification, and therapeutic strategies (2026) · cites this paper as [10]
In the citing paper
“a 2023 scoping review identified IL-6, TNF-alpha, and neopterin as the most consistent neuroimmune biomarkers linking HIV to depression, with chronically activated microglia proposed as the central mechanistic node [9, 10].”
From Neuroinflammation and depression: immune-brain interface mechanisms, biomarker stratification, and therapeutic strategies (2026) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Validity of the brief patient health questionnaire mood scale (PHQ-9) in the general population
Martin, A., Rief, W., Klaiberg, A., & Braehler, E. (2006) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2005.07.003 · Cited by 1,379
Chronic stress and age-related increases in the proinflammatory cytokine IL-6.
Kiecolt-Glaser, J. K., Preacher, K. J., MacCallum, R. C., Atkinson, C., Malarkey, W. B., & Glaser, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1531903100 · Cited by 1,267
EQ-5D and the EuroQol group: past, present and future
Devlin, N. J., & Brooks, R. (2017) · Applied Health Economics and Health Policy · doi:10.1007/s40258-017-0310-5 · Cited by 1,189
Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects
Badawy, A. A.-B. (2017) · International Journal of Tryptophan Research · doi:10.1177/1178646917691938 · Cited by 1,158 · cited 9×
“(189) Indoleamine-2, 3-dioxygenase and other interferon-gamma-mediated pathways in PLWH. Neuroin fl ammation increases the activity of IDO in PLWH.”
InfluentialVitamin D deficiency and depression in adults: systematic review and meta-analysis
Anglin, R. E. S., Samaan, Z., Walter, S. D., & McDonald, S. D. (2013) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.106666 · Cited by 820
A Swedish National Twin Study of Lifetime Major Depression
Kendler, K. S., Gatz, M., Gardner, C. O., & Pedersen, N. L. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.109 · Cited by 794 · cited 1×
“In 2006, a twin study with a very large sample size was conducted in Sweden (63).”
Dopamine system dysregulation in major depressive disorders
Belujon, P., & Grace, A. A. (2017) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx056 · Cited by 754 · cited 3×
“Over time, anxiety and/or depression may thus manifest (160).”
Mental health and HIV/AIDS: the need for an integrated response
Remien, R. H., Stirratt, M. J., Nguyen, N., Robbins, R. N., Pala, A. N., & Mellins, C. A. (2019) · AIDS · doi:10.1097/qad.0000000000002227 · Cited by 727
Marsland, A. L., Walsh, C., Lockwood, K., & John-Henderson, N. A. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.01.011 · Cited by 691
Research works printed but not linked: 247
- Luxton, 2022, Depression in children and young people: identification and management NICE guidelines, Arch Dis Child Educ Pract Ed, 107, 10.1136/archdischild-2020-320020 · DOI
- Edinoff, 2021, Selective serotonin reuptake inhibitors and adverse effects: A narrative review, Neurol Int, 13, 387, 10.3390/neurolint13030038 · DOI · Paper page
- Gebru, 2024, Prevalence of depression and associated factors among HIV/AIDS patients attending antiretroviral therapy clinic at Adama Hospital Medical College, Adama, Central Ethiopia, Sci Rep, 14, 1642, 10.1038/s41598-024-52142-z · DOI
- Xu, 2017, MicroRNAs upregulated during HIV infection target peroxisome biogenesis factors: Implications for virus biology, disease mechanisms and neuropathology, PLoS Pathog, 13, 10.1371/journal.ppat.1006360 · DOI · Paper page
- Muche, 2020, Patient reported central nervous system adverse events of efavirenz-based antiretroviral therapy in people living with HIV in northwest Ethiopia, HIV AIDS (Auckl), 12, 10.2147/hiv.s276111 · doi:10.2147/hiv.s276111
- Sekine, 2023, Adherence to anti-retroviral therapy, decisional conflicts, and health-related quality of life among treatment-naïve individuals living with HIV: a DEARS-J observational study, J Pharm Health Care Sci, 9, 9, 10.1186/s40780-023-00277-y · DOI
- Troncoso, 2015, Prevalence of neurocognitive disorders and depression in a Brazilian HIV population, Rev Soc Bras Med Trop, 48, 10.1590/0037-8682-0034-2015 · DOI
- Burki, 2022, Guidelines for visceral leishmaniasis and HIV co-infection, Lancet Infect Dis, 22, 10.1016/s1473-3099(22)00461-3 · doi:10.1016/s1473-3099(22)00461-3
- Niu, 2016, The mental health of people living with HIV in China, 1998-2014: A systematic review, PLoS One, 11, 10.1371/journal.pone.0153489 · DOI
- Niu, 2019, Longitudinal trajectories of emotional problems and unmet mental health needs among people newly diagnosed with HIV in China, J Int AIDS Soc, 22, 10.1002/jia2.25332 · DOI
- Jiang, 2019, Prevalence of and factors associated with major depressive disorder among HIV-positive individuals in Guangdong, China, J Affect Disord, 246, 10.1016/j.jad.2018.12.130 · DOI
- Lofgren, 2020, Burden of depression in outpatient HIV-infected adults in sub-Saharan Africa; systematic review and meta-analysis, AIDS Behav, 24, 10.1007/s10461-019-02706-2 · DOI
- Choi, 2016, Prevalence, recurrence, and incidence of current depressive symptoms among people living with HIV in Ontario, Canada: results from the Ontario HIV treatment network cohort study, PLoS One, 11, 10.1371/journal.pone.0165816 · DOI
- Pence, 2018, Association of increased chronicity of depression with HIV appointment attendance, treatment failure, and mortality among HIV-infected adults in the United States, JAMA Psychiatry, 75, 10.1001/jamapsychiatry.2017.4726 · DOI · Paper page
- Woods, 2023, Under-representation of low and middle income countries (LMIC) in the research literature: Ethical issues arising from a survey of five leading medical journals: have the trends changed, Glob Public Health, 18, 10.1080/17441692.2023.2229890 · DOI
- Chibanda, 2017, Depression and HIV: integrated care towards 90-90-90, Int Health, 9, 10.1093/inthealth/ihw058 · DOI
- Ngum, 2017, Depression among HIV/AIDS patients on highly active antiretroviral therapy in the southwest regional hospitals of Cameroon: A cross-sectional study, Neurol Ther, 6, 10.1007/s40120-017-0065-9 · DOI
- Amare, 2018, Prevalence and associated factors of depression among PLHIV in Ethiopia: systematic review and meta-analysis, 2017, AIDS Res Treat, 2018, 10.1155/2018/5462959 · DOI
- Sarno, 2021, Neuroimmunology of depression, Adv Pharmacol, 91, 10.1016/bs.apha.2021.03.004 · DOI
- Juruena, 2018, Atypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic review, J Affect Disord, 233, 45, 10.1016/j.jad.2017.09.052 · DOI · Paper page
- Bhatt, 2023, Targeting inflammation: a potential approach for the treatment of depression, Metab Brain Dis, 38, 45, 10.1007/s11011-022-01095-1 · DOI
- Loula, 2022, Monoamine neurotransmitters and mood swings: a dynamical systems approach, Math Biosci Eng, 19, 10.3934/mbe.2022187 · DOI
- Beck, 1996, Manual for the beck depression inventory-II, psychol Corporation, 10.1037/t00742-000 · DOI · Paper page
- Osman, 2004, Reliability and validity of the beck depression inventory-II with adoslescent psychiatric inpatients, psychol Assess, 16, 10.1037/1040-3590.16.2.120 · DOI · Paper page
- Beck, 1961, An inventory for measuring depression, Arch Gen Psychiatry, 4, 10.1001/archpsyc.1961.01710120031004 · DOI · Paper page
- Radloff, 1977, The CES-D scale:A self-report depression scale for research in the general population, Appl psychol Measurement, 1, 385, 10.1177/014662167700100306 · DOI · Paper page
- Saracino, 2020, Confirmatory factor analysis of the center for epidemiologic studies depression scale in oncology with examination of invariance between younger and Older patients, Eur J psychol Assess, 36, 10.1027/1015-5759/a000510 · DOI
- 1990, EuroQol - a new facility for the measurement of health-related quality of life, Health Policy, 16, 199, 10.1016/0168-8510(90)90421-9 · DOI · Paper page
- Brooks, 1996, EuroQol: the current state of play, Health Policy, 37, 53, 10.1016/0168-8510(96)00822-6 · DOI · Paper page
- Hamilton, 1960, Rating scale for depression, J Neurology Neurosurg Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 · DOI · Paper page
- Montgomery, 2018, A new depression scale designed to be sensitive to change, Br J Psychiatry, 134, 10.1192/bjp.134.4.382 · DOI · Paper page
- D’Zurilla, 1990, Development and preliminary evaluation of the socialproblem-solving inventory, psychol Assess, 2
- D’Zurilla, 2002, Social problem-solving inventory-revised (SPSI-R), Multi-Health Syst
- Meranda, 1996, BASC: behavior assessment system for children, Measurement Eval Couns Dev, 28
- Reynolds, 2015, Behavior assessment system for children (3rd ed.), Pearson Assessments
- Achenbach, 1978, The child behavior profile: an empirically based system for assessing children’s behavioral problems and competencies, Int J Ment Health, 7, 24, 10.1080/00207411.1978.11448806 · DOI · Paper page
- Kariuki, 2016, Evaluation of psychometric properties and factorial structure of the pre-school child behaviour checklist at the Kenyan Coast, Child Adolesc Psychiatry Ment Health, 10, 10.1186/s13034-015-0089-9 · DOI
- Kovacs, 1981, Rating scales to assess depression in school-aged children, Acta Paedopsychiatrica: Int J Child &Adolescent Psychiatry, 46
- Sun, 2015, The children’s depression inventory in worldwide child development research: A reliability generalization study, J Child Family Stud, 24, 10.1007/s10826-014-0038-x · DOI
- Poznanski, 1979, A depression rating scale for children, Pediatrics, 64, 10.1542/peds.64.4.442 · DOI · Paper page
- Mayes, 2010, Psychometric properties of the children’s depression rating scale–revised in adolescents, J Child Adolesc Psychopharmacol, 20, 10.1089/cap.2010.0063 · DOI · Paper page
- Neufeld, 2010, Enhanced measurement sensitivity of hopeless ideation among older adults at risk of self-harm: Reliability and validity of Likert-type responses to the Beck Hopelessness Scale, Aging Ment Health, 14, 10.1080/13607860903421052 · DOI · Paper page
- Rush, 2003, The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression, Biol Psychiatry, 54, 10.1016/S0006-3223(02)01866-8 · DOI · Paper page
- Robitaille, 2010, Factorial structure and psychometric properties of the reminiscence functions scale, Aging Ment Health, 14, 10.1080/13607860903167820 · DOI
- Webster, 1993, Construction and validation of the reminiscence functions scale, J Gerontology, 48, 10.1093/geronj/48.5.P256 · DOI · Paper page
- Ware, 1992, The MOS 36-ltem short-form health survey (SF-36): I. Conceptual framework and item selection, Med Care, 30, 10.1097/00005650-199206000-00002 · DOI · Paper page
- Gameroff, 2012, Testing the short and screener versions of the social adjustment scale – self-report (SAS-SR), Int J Methods Psychiatr Res, 21, 52, 10.1002/mpr.358 · DOI · Paper page
- Weissman, 1976, Assessment of social adjustment by patient self-report, Arch Gen Psychiatry, 33, 10.1001/archpsyc.1976.01770090101010 · DOI · Paper page
- Tyrer, 2005, The social functioning questionnaire: A rapid and robust measure of perceived functioning, Int J Soc Psychiatry, 51, 10.1177/0020764005057391 · DOI · Paper page
- Lopez, 2010, A psychometric study of the geriatric depression scale, Eur J psychol Assess, 26, 55, 10.1027/1015-5759/a000008 · DOI · Paper page
- Yesavage, 1982, Development and validation of a geriatric depression screening scale: A preliminary report, J Psychiatr Res, 17, 37, 10.1016/0022-3956(82)90033-4 · DOI · Paper page
- Neugarten, 1961, The measurement of life satisfaction*, J Gerontology, 16, 10.1093/geronj/16.2.134 · DOI · Paper page
- Adams, 1969, Analysis of a life satisfaction index, J Gerontology, 24, 10.1093/geronj/24.4.470 · DOI · Paper page
- Sullivan, 2000, Genetic epidemiology of major depression: review and meta-analysis, Am J Psychiatry, 157, 10.1176/appi.ajp.157.10.1552 · DOI · Paper page
- Tansey, 2013, Contribution of common genetic variants to antidepressant response, Biol Psychiatry, 73, 10.1016/j.biopsych.2012.10.030 · DOI · Paper page
- Cardenas, 2023, Prevention of the vertical transmission of HIV; A recap of the journey so far, Viruses, 15, 10.3390/v15040849 · DOI
- Yao, 2019, The roles of microRNAs in epigenetic regulation, Curr Opin Chem Biol, 51, 10.1016/j.cbpa.2019.01.024 · DOI · Paper page
- Bao, 2004, MicroRNA binding sites in Arabidopsis class III HD-ZIP mRNAs are required for methylation of the template chromosome, Dev Cell, 7, 10.1016/j.devcel.2004.10.003 · DOI · Paper page
- Rajewsky, 2006, microRNA target predictions in animals, Nat Genet, S8, 10.1038/ng1798 · DOI · Paper page
- Juźwik, 2019, microRNA dysregulation in neurodegenerative diseases: A systematic review, Prog Neurobiol, 182, 10.1016/j.pneurobio.2019.101664 · DOI · Paper page
- Rashid, 2022, The diverse roles of miRNAs in HIV pathogenesis: Current understanding and future perspectives, Front Immunol, 13, 10.3389/fimmu.2022.1091543 · DOI
- Eletto, 2008, Inhibition of SNAP25 expression by HIV-1 Tat involves the activity of mir-128a, J Cell Physiol, 216, 10.1002/jcp.21452 · DOI · Paper page
- Mukerjee, 2011, Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders, J Biol Chem, 286, 10.1074/jbc.M111.241547 · DOI
- Yelamanchili, 2010, MicroRNA-21 dysregulates the expression of MEF2C in neurons in monkey and human SIV/HIV neurological disease, Cell Death Dis, 1, 10.1038/cddis.2010.56 · DOI
- Ryan, 2019, Peroxisome proliferator-activated receptor gamma co-activator-1 alpha in depression and the response to electroconvulsive therapy, Psychol Med, 49, 10.1017/s0033291718002556 · DOI
- Bol, 2012, Single nucleotide polymorphism in gene encoding transcription factor Prep1 is associated with HIV-1-associated dementia, PLoS One, 7, 10.1371/journal.pone.0030990 · DOI
- Jasinska, 2022, CCR5 as a coreceptor for human immunodeficiency virus and simian immunodeficiency viruses: A prototypic love-hate affair, Front Immunol, 13, 10.3389/fimmu.2022.835994 · DOI
- Sundermann, 2015, Genetic predictor of working memory and prefrontal function in women with HIV, J Neurovirol, 21, 81, 10.1007/s13365-014-0305-z · DOI
- Mikulska, 2021, HPA axis in the pathomechanism of depression and schizophrenia: new therapeutic strategies based on its participation, Brain Sci, 11, 10.3390/brainsci11101298 · DOI · Paper page
- Timmermans, 2019, A general introduction to glucocorticoid biology, Front Immunol, 10, 10.3389/fimmu.2019.01545 · DOI · Paper page
- Matosin, 2023, Associations of psychiatric disease and ageing with FKBP5 expression converge on superficial layer neurons of the neocortex, Acta Neuropathol, 145, 10.1007/s00401-023-02541-9 · DOI
- Podgorny, 2021, Glucocorticoid-mediated mechanisms of hippocampal damage: Contribution of subgranular neurogenesis, J Neurochem, 157, 10.1111/jnc.15265 · DOI
- Zacková, 2021, Cognitive impairment and depression: Meta-analysis of structural magnetic resonance imaging studies, NeuroImage Clin, 32, 10.1016/j.nicl.2021.102830 · DOI · Paper page
- Lubitz, 2022, Adrenal function in HIV infection, 10.1007/978-3-030-84367-0_62 · DOI
- Villette, 1990, Circadian variations in plasma levels of hypophyseal, adrenocortical and testicular hormones in men infected with human immunodeficiency virus, J Clin Endocrinol Metab, 70, 10.1210/jcem-70-3-572 · DOI · Paper page
- Dobs, 1988, Endocrine disorders in men infected with human immunodeficiency virus, Am J Med, 84, 10.1016/0002-9343(88)90144-1 · DOI · Paper page
- Nassoro, 2019, Adrenal insufficiency: A forgotten diagnosis in HIV/AIDS patients in developing countries, Int J Endocrinol, 2019, 10.1155/2019/2342857 · DOI
- Mathavan, 2022, Management of adrenal insufficiency in the setting of chronic HIV and advanced extra-adrenal Hodgkin lymphoma, BMJ Case Rep, 15, 10.1136/bcr-2022-249269 · DOI
- Odeniyi, 2013, Adrenocortical function in Nigerians with human immunodeficiency virus infection, Ghana Med J, 47
- Lo, 2010, Adrenal function in HIV infection, Curr Opin Endocrinol Diabetes Obes, 17, 10.1097/MED.0b013e3283394441 · DOI
- Akase, 2018, Occurrence of hypocortisolism in HIV patients: Is the picture changing, Ghana Med J, 52, 10.4314/gmj.v52i3.7 · doi:10.4314/gmj.v52i3.7
- Ferreiro, 1988, Pathology of the pituitary gland in patients with the acquired immune deficiency syndrome (AIDS), Pathology, 20, 10.3109/00313028809059495 · doi:10.3109/00313028809059495
- Bertorini, 2014, Neurologic complications of disorders of the adrenal glands, Handb Clin Neurol, 120, 10.1016/b978-0-7020-4087-0.00050-4 · DOI
- Almeida, 2020, Adrenal insufficiency and glucocorticoid use during the COVID-19 pandemic, Clinics (Sao Paulo), 75, 10.6061/clinics/2020/e2022 · DOI
- Norbiato, 1992, Cortisol resistance in acquired immunodeficiency syndrome, J Clin Endocrinol Metab, 74, 10.1210/jcem.74.3.1740494 · doi:10.1210/jcem.74.3.1740494 · Paper page
- Vagnucci, 1993, Circadian rhythm of lymphocytes and their glucocorticoid receptors in HIV-infected homosexual men, J Acquir Immune Defic Syndr (1988), 6
- Benido Silva, 2023, Iatrogenic Cushing’s syndrome: the result of cobicistat and glucocorticoid interaction in an HIV patient after bariatric surgery, Cureus, 15, 10.7759/cureus.34367 · DOI
- Fazeli, 2017, Moment-to-moment within-person associations between acts of discrimination and internalized stigma in people living with HIV: An experience sampling study, Stigma Health, 2, 10.1037/sah0000051 · DOI
- Garrido-Hernansaiz, 2020, Predictors of anxiety and depression among newly diagnosed people living with HIV: A longitudinal study, Scand J Psychol, 61, 10.1111/sjop.12621 · DOI
- Juruena, 2020, The role of early life stress in HPA axis and anxiety, Adv Exp Med Biol, 1191, 10.1007/978-981-32-9705-0_9 · DOI · Paper page
- Naughton, 2014, Corticotropin-releasing hormone and the hypothalamic-pituitary-adrenal axis in psychiatric disease, Handb Clin Neurol, 124, 69, 10.1016/b978-0-444-59602-4.00005-8 · DOI
- Song, 2011, Cytokines mediated inflammation and decreased neurogenesis in animal models of depression, Prog Neuropsychopharmacol Biol Psychiatry, 35, 10.1016/j.pnpbp.2010.06.020 · DOI · Paper page
- Liu, 2003, Suppression of hippocampal neurogenesis is associated with developmental stage, number of perinatal seizure episodes, and glucocorticosteroid level, Exp Neurol, 184, 196, 10.1016/s0014-4886(03)00207-3 · DOI · Paper page
- Bolshakov, 2021, Glucocorticoids: Dr. Jekyll and Mr. Hyde of hippocampal neuroinflammation, Biochem (Mosc), 86, 10.1134/s0006297921020048 · DOI
- Yang, 2021, Interleukin-1 family and serotonin transporter in first-episode, drug-naive major depressive disorder: A pilot study, J Psychiatr Res, 135, 10.1016/j.jpsychires.2021.01.018 · DOI
- Zádor, 2021, Pro-inflammatory cytokines: potential links between the endocannabinoid system and the kynurenine pathway in depression, Int J Mol Sci, 22, 10.3390/ijms22115903 · DOI
- Ramírez, 2018, A new theory of depression based on the serotonin/kynurenine relationship and the hypothalamicpituitary- adrenal axis, Biomedica, 38, 10.7705/biomedica.v38i3.3688 · DOI
- Carlos, 2017, IL-1β impairs retrograde flow of BDNF signaling by attenuating endosome trafficking, J Neuroinflamm, 14, 10.1186/s12974-017-0803-z · DOI · Paper page
- Ash, 2021, HIV in the brain: identifying viral reservoirs and addressing the challenges of an HIV cure, Vaccines (Basel), 9, 10.3390/vaccines9080867 · DOI
- Rojas-Celis, 2019, New challenges of HIV-1 infection: how HIV-1 attacks and resides in the central nervous system, Cells, 8, 10.3390/cells8101245 · DOI
- Izquierdo-Useros, 2010, HIV and mature dendritic cells: Trojan exosomes riding the Trojan horse, PloS Pathog, 6, 10.1371/journal.ppat.1000740 · DOI · Paper page
- Krishnan, 2008, The molecular neurobiology of depression, Nature, 455, 894, 10.1038/nature07455 · DOI · Paper page
- Saloner, 2021, Chronically elevated depressive symptoms interact with acute increases in inflammation to predict worse neurocognition among people with HIV, J Neurovirol, 27, 10.1007/s13365-020-00925-1 · DOI
- Uint, 2019, Increased levels of plasma IL-1b and BDNF can predict resistant depression patients, Rev Assoc Med Bras (1992), 65, 10.1590/1806-9282.65.3.361 · DOI
- Salvo-Romero, 2020, Microbiota-immune interactions: from gut to brain, LymphoSign J, 7, 10.14785/lymphosign-2019-0018 · DOI
- Mussano, 2016, Cytokine, chemokine, and growth factor profile of platelet-rich plasma, Platelets, 27, 10.3109/09537104.2016.1143922 · DOI · Paper page
- Williams, 2024, The relationship between HIV-1 neuroinflammation, neurocognitive impairment and encephalitis pathology: A systematic review of studies investigating post-mortem brain tissue, Rev Med Virol, 34, e2519, 10.1002/rmv.2519 · DOI
- Feria, 2018, HIV replication is associated to inflammasomes activation, IL-1β, IL-18 and caspase-1 expression in GALT and peripheral blood, PLoS One, 13, 10.1371/journal.pone.0192845 · DOI
- Nabatanzi, 2023, Increased levels of caspase-1 and IL-1β Among adults with persistent immune activation after 12 years of suppressive antiretroviral therapy in the infectious diseases institute HIV treatment cohort, Open Forum Infect Dis, 10, 10.1093/ofid/ofad539 · DOI
- Ting, 2020, Role of interleukin-6 in depressive disorder, Int J Mol Sci, 21, 10.3390/ijms21062194 · DOI · Paper page
- Koutsouraki, 2011, Increase in interleukin-6 levels is related to depressive phenomena in the acute (relapsing) phase of multiple sclerosis, J Neuropsychiatry Clin Neurosci, 23, 10.1176/jnp.23.4.jnp442 · DOI
- Jehn, 2010, Association of IL-6, hypothalamus-pituitary-adrenal axis function, and depression in patients with cancer, Integr Cancer Ther, 9, 10.1177/1534735410370036 · DOI · Paper page
- Darcy, 2020, The link between stress and IL-6 is heating up, Cell Metab, 32, 10.1016/j.cmet.2020.07.011 · DOI
- Gotohda, 2008, Significant correlation between surgical stress of hepatectomy and changes in the serum levels of HGF, IL-6 and soluble Fas in patients with viral hepatitis, Hepatogastroenterology, 55
- Armah, 2012, HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation, Clin Infect Dis, 55, 10.1093/cid/cis406 · DOI · Paper page
- Kalliolias, 2016, TNF biology, pathogenic mechanisms and emerging therapeutic strategies, Nat Rev Rheumatol, 12, 49, 10.1038/nrrheum.2015.169 · DOI · Paper page
- van Loo, 2023, Death by TNF: a road to inflammation, Nat Rev Immunol, 23, 289, 10.1038/s41577-022-00792-3 · DOI · Paper page
- Probert L., 2015, and its receptors in the CNS: The essential, the desirable and the deleterious effects, Neuroscience, 302, 2, 10.1016/j.neuroscience.2015.06.038 · DOI · Paper page
- Ma, 2016, Pathogenetic and therapeutic applications of tumor necrosis factor-α (TNF-α) in major depressive disorder: A systematic review, Int J Mol Sci, 17, 10.3390/ijms17050733 · DOI · Paper page
- Ownby, 2009, Tumor necrosis factor-alpha levels in HIV-1 seropositive injecting drug users, J Neuroimmune Pharmacol, 4, 10.1007/s11481-009-9150-x · DOI
- Okay, 2020, The effect of antiretroviral therapy on IL-6, IL-1β, TNF-α, IFN-γ Levels and their relationship with HIV-RNA and CD4+ T cells in HIV patients, Curr HIV Res, 18, 10.2174/1570162x18666200712174642 · DOI
- Derry, 2022, Links between inflammation, mood, and physical function among older adults with HIV, J Gerontol B Psychol Sci Soc Sci, 77, 50, 10.1093/geronb/gbab027 · DOI
- Derry-Vick, 2022, Pain is associated with depressive symptoms, inflammation, and poorer physical function in older adults with HIV, Psychosom Med, 84, 10.1097/psy.0000000000001119 · DOI
- Memiah, 2021, Mental health symptoms and inflammatory markers among HIV infected patients in Tanzania, BMC Public Health, 21, 1113, 10.1186/s12889-021-11064-5 · DOI
- Rivera-Rivera, 2014, Depression correlates with increased plasma levels of inflammatory cytokines and a dysregulated oxidant/antioxidant balance in HIV-1-infected subjects undergoing antiretroviral therapy, J Clin Cell Immunol, 5, 10.4172/2155-9899.1000276 · DOI
- Milenkovic, 2019, The role of chemokines in the pathophysiology of major depressive disorder, Int J Mol Sci, 20, 10.3390/ijms20092283 · DOI · Paper page
- Romero-Sanchiz, 2020, Variation in chemokines plasma concentrations in primary care depressed patients associated with Internet-based cognitive-behavioral therapy, Sci Rep, 10, 1078, 10.1038/s41598-020-57967-y · DOI
- Lin, 2017, Plasma cytokines and chemokines in Zambian children with measles: innate responses and association with HIV-1 coinfection and in-hospital mortality, J Infect Dis, 215, 10.1093/infdis/jix012 · DOI
- Mamik, 2016, CXCL8 as a potential therapeutic target for HIV-associated neurocognitive disorders, Curr Drug Targets, 17, 10.2174/1389450116666150626124544 · doi:10.2174/1389450116666150626124544
- Lehmann, 2019, Nef-induced CCL2 expression contributes to HIV/SIV brain invasion and neuronal dysfunction, Front Immunol, 10, 10.3389/fimmu.2019.02447 · DOI
- Schaller, 2017, Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3, Expert Rev Clin Immunol, 13, 10.1080/1744666x.2017.1384313 · DOI · Paper page
- Flórez-Álvarez, 2018, NK cells in HIV-1 infection: from basic science to vaccine strategies, Front Immunol, 9, 10.3389/fimmu.2018.02290 · DOI
- Rubin, 2020, Remitted depression and cognition in HIV: The role of cortisol and inflammation, Psychoneuroendocrinology, 114, 10.1016/j.psyneuen.2020.104609 · DOI
- Lu, 2019, Inflammation and risk of depression in HIV: prospective findings from the multicenter AIDS cohort study, Am J Epidemiol, 188, 1994, 10.1093/aje/kwz190 · DOI
- Mudra Rakshasa-Loots, 2023, Depression and HIV: a scoping review in search of neuroimmune biomarkers, Brain Commun, 5, 10.1093/braincomms/fcad231 · DOI · Paper page
- Nutt, 2008, Relationship of neurotransmitters to the symptoms of major depressive disorder, J Clin Psychiatry, 4
- Perez-Caballero, 2019, Monoaminergic system and depression, Cell Tissue Res, 377, 10.1007/s00441-018-2978-8 · DOI · Paper page
- Dailly, 2004, Dopamine, depression and antidepressants, Fundam Clin Pharmacol, 18, 10.1111/j.1472-8206.2004.00287.x · DOI · Paper page
- Zhang, 2017, Depression and anxiety behaviour in a rat model of chronic migraine, J Headache Pain, 18, 27, 10.1186/s10194-017-0736-z · DOI
- Mällo, 2007, Rats with persistently low or high exploratory activity: behaviour in tests of anxiety and depression, and extracellular levels of dopamine, Behav Brain Res, 177, 10.1016/j.bbr.2006.11.022 · DOI
- Martin-Soelch, 2009, Is depression associated with dysfunction of the central reward system, Biochem Soc Trans, 37, 10.1042/bst0370313 · DOI
- Tamura, 2022, Dopamine dysfunction in depression: application of texture analysis to dopamine transporter single-photon emission computed tomography imaging, Transl Psychiatry, 12, 309, 10.1038/s41398-022-02080-z · DOI
- Monick, 2022, Characterization of basal ganglia volume changes in the context of HIV and polysubstance use, Sci Rep, 12, 4357, 10.1038/s41598-022-08364-0 · DOI
- Saloner, 2020, Lower CSF homovanillic acid relates to higher burden of neuroinflammation and depression in people with HIV disease, Brain Behav Immun, 90, 10.1016/j.bbi.2020.09.012 · DOI
- Goulding, 2019, Age-related decrease in tyrosine hydroxylase immunoreactivity in the substantia nigra and region-specific changes in microglia morphology in HIV-1 Tg rats, Neurotox Res, 36, 10.1007/s12640-019-00077-z · DOI
- Kumar, 2009, Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains, J Neurovirol, 15, 10.1080/13550280902973952 · DOI
- Ko, 2019, Macrophages but not Astrocytes Harbor HIV DNA in the Brains of HIV-1-Infected Aviremic Individuals on Suppressive Antiretroviral Therapy, J Neuroimmune Pharmacol, 14, 10.1007/s11481-018-9809-2 · DOI · Paper page
- Miller, 2018, HIV-1 Tat regulation of dopamine transmission and microglial reactivity is brain region specific, Glia, 66, 10.1002/glia.23447 · DOI
- Mishra, 2018, Expression of complement receptor 3 (CR3) and regulatory protein CD46 on dendritic cells of antiretroviral naïve and treated HIV-1 infected individuals: Correlation with immune activation status, Mol Immunol, 96, 10.1016/j.molimm.2018.02.011 · doi:10.1016/j.molimm.2018.02.011
- Roscoe, 2014, HIV-1 transgenic female rat: synaptodendritic alterations of medium spiny neurons in the nucleus accumbens, J Neuroimmune Pharmacol, 9, 10.1007/s11481-014-9555-z · DOI
- Bakshi, 2024, Biochemistry, serotonin
- De Deurwaerdère, 2020, Serotonin in health and disease, Int J Mol Sci, 21, 10.3390/ijms21103500 · doi:10.3390/ijms21103500
- Bamalan, 2024, Physiology, serotonin
- Aleksovski, 2018, SSRI-reduced platelet reactivity in non-responding patients with life-long Recurrent Depressive Disorder: Detection and involved mechanisms, Thromb Res, 165, 24, 10.1016/j.thromres.2018.03.006 · DOI
- Park, 2018, Antidepressant-like effects of Gyejibokryeong-Hwan in a mouse model of reserpine-induced depression, BioMed Res Int, 2018, 10.1155/2018/5845491 · DOI
- Liu, 2018, Emotional roles of mono-aminergic neurotransmitters in major depressive disorder and anxiety disorders, Front Psychol, 9, 10.3389/fpsyg.2018.02201 · DOI · Paper page
- Zięba, 2021, Overcoming depression with 5-HT(2A) receptor ligands, Int J Mol Sci, 23, 10.3390/ijms23010010 · DOI
- Wang, 2021, Abnormal tryptophan metabolism in HIV and mycobacterium tuberculosis infection, Front Microbiol, 12, 10.3389/fmicb.2021.666227 · DOI
- Le Floc’h, 2011, Tryptophan metabolism, from nutrition to potential therapeutic applications, Amino Acids, 41, 10.1007/s00726-010-0752-7 · DOI · Paper page
- Friedman, 2018, Analysis, nutrition, and health benefits of tryptophan, Int J Tryptophan Res, 11, 10.1177/1178646918802282 · DOI · Paper page
- Baumgartner, 2019, The interplay between cytokines and the Kynurenine pathway in inflammation and atherosclerosis, Cytokine, 122, 154148, 10.1016/j.cyto.2017.09.004 · DOI · Paper page
- Schroecksnadel, 2007, Indoleamine-2, 3-dioxygenase and other interferon-gamma-mediated pathways in patients with human immunodeficiency virus infection, Curr Drug Metab, 8, 10.2174/138920007780362608 · DOI · Paper page
- Murray, 2003, Tryptophan depletion and HIV infection: a metabolic link to pathogenesis, Lancet Infect Dis, 3, 10.1016/s1473-3099(03)00773-4 · DOI
- Ferrell, 2014, The impact of HIV-1 on neurogenesis: implications for HAND, Cell Mol Life Sci, 71, 10.1007/s00018-014-1702-4 · DOI
- Valles-Colomer, 2019, The neuroactive potential of the human gut microbiota in quality of life and depression, Nat Microbiol, 4, 10.1038/s41564-018-0337-x · DOI · Paper page
- Geng, 2020, Regulation of gut microbiota on immune reconstitution in patients with acquired immunodeficiency syndrome, Front Microbiol, 11, 10.3389/fmicb.2020.594820 · DOI
- van Marle, 2013, Gastrointestinal viral load and enteroendocrine cell number are associated with altered survival in HIV-1 infected individuals, PLoS One, 8, 10.1371/journal.pone.0075967 · DOI
- Shah, 2019, Potential mechanism for HIV-associated depression: upregulation of serotonin transporters in SIV-infected macaques detected by 11C-DASB PET, Front Psychiatry, 10, 10.3389/fpsyt.2019.00362 · DOI
- Hussain, 2024, Physiology, noradrenergic synapse
- Fiore, 2023, Norepinephrine regulates calcium signals and fate of oligodendrocyte precursor cells in the mouse cerebral cortex, Nat Commun, 14, 8122, 10.1038/s41467-023-43920-w · DOI
- Maletic, 2017, The role of norepinephrine and its α-adrenergic receptors in the pathophysiology and treatment of major depressive disorder and schizophrenia: A systematic review, Front Psychiatry, 8, 10.3389/fpsyt.2017.00042 · DOI · Paper page
- Khurana, 2019, Lacidipine attenuates reserpine-induced depression-like behavior and oxido-nitrosative stress in mice, Naunyn Schmiedebergs Arch Pharmacol, 392, 10.1007/s00210-019-01667-6 · DOI
- Sattar, 2018, A review of the mechanism of antagonism of N-methyl-D-aspartate receptor by ketamine in treatment-resistant depression, Cureus, 10, 10.7759/cureus.2652 · DOI
- Fayez, 2024, Imipramine
- Ironson, 2015, Psychosocial and neurohormonal predictors of HIV disease progression (CD4 cells and viral load): A 4 year prospective study, AIDS Behav, 19, 10.1007/s10461-014-0877-x · DOI
- Saloner, 2020, Cerebrospinal fluid norepinephrine and neurocognition in HIV and methamphetamine dependence, J Acquir Immune Defic Syndr, 85, 10.1097/qai.0000000000002422 · DOI
- Potter, 2013, Targeting the glutamatergic system for the treatment of HIV-associated neurocognitive disorders, J Neuroimmune Pharmacol, 8, 594, 10.1007/s11481-013-9442-z · DOI · Paper page
- Marino, 2020, Functional impact of HIV-1 Tat on cells of the CNS and its role in HAND, Cell Mol Life Sci, 77, 10.1007/s00018-020-03561-4 · DOI
- Vázquez-Santiago, 2014, Glutamate metabolism and HIV-associated neurocognitive disorders, J Neurovirol, 20, 10.1007/s13365-014-0258-2 · DOI
- Mudra Rakshasa-Loots, 2022, Neuroinflammation in HIV-associated depression: evidence and future perspectives, Mol Psychiatry, 27, 10.1038/s41380-022-01619-2 · DOI
- Michael, 2020, The role of brain derived neurotrophic factor in HIV-associated neurocognitive disorder: from the bench-top to the bedside, Neuropsychiatr Dis Treat, 16, 10.2147/ndt.s232836 · DOI
- Hu, 2024, HIV-associated neurocognitive disorder: key implications of the microbiota-gut-brain axis, Front Microbiol, 15, 10.3389/fmicb.2024.1428239 · DOI
- Winias, 2020, Neuropathy complication of antiretroviral therapy in HIV/AIDS patients, Oral Dis, 10.1111/odi.13398 · DOI
- Drury, 2018, HIV and mental illness in Malawi and the neuropsychiatric sequelae of efavirenz, Malawi Med J, 30, 10.4314/mmj.v30i1.9 · DOI
- Xia, 2021, Switching from efavirenz to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide reduces central nervous system symptoms in people living with HIV, Chin Med J (Engl), 134, 10.1097/cm9.0000000000001824 · doi:10.1097/cm9.0000000000001824
- Zareifopoulos, 2020, Neuropsychiatric effects of antiviral drugs, Cureus, 12, 10.7759/cureus.9536 · DOI
- Costa, 2022, Efavirenz: history, development and future, Biomolecules, 13, 10.3390/biom13010088 · DOI
- Apostolova, 2015, Efavirenz and the CNS: what we already know and questions that need to be answered, J Antimicrob Chemother, 70, 10.1093/jac/dkv183 · DOI · Paper page
- Cocohoba, 2008, Raltegravir: the first HIV integrase inhibitor, Clin Ther, 30, 10.1016/j.clinthera.2008.10.012 · DOI
- Fantauzzi, 2014, Dolutegravir: clinical efficacy and role in HIV therapy, Ther Adv Chronic Dis, 5, 10.1177/2040622314530461 · DOI
- Cid-Silva, 2017, Clinical experience with the integrase inhibitors dolutegravir and elvitegravir in HIV-infected patients: efficacy, safety and tolerance, Basic Clin Pharmacol Toxicol, 121, 10.1111/bcpt.12828 · doi:10.1111/bcpt.12828
- Hoffmann, 2017, Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patients, HIV Med, 18, 56, 10.1111/hiv.12468 · DOI
- Hoffmann, 2019, Neuropsychiatric adverse events with dolutegravir and other integrase strand transfer inhibitors, AIDS Rev, 21, 4, 10.24875/AIDSRev.19000023 · DOI
- Stern, 2018, Differential effects of antiretroviral drugs on neurons in vitro: roles for oxidative stress and integrated stress response, J Neuroimmune Pharmacol, 13, 64, 10.1007/s11481-017-9761-6 · DOI
- Nooka, 2018, Organellar stress intersects the astrocyte endoplasmic reticulum, mitochondria and nucleolus in HIV associated neurodegeneration, Cell Death Dis, 9, 317, 10.1038/s41419-018-0341-3 · DOI
- Ekins, 2017, α7-Nicotinic acetylcholine receptor inhibition by indinavir: implications for cognitive dysfunction in treated HIV disease, Aids, 31, 10.1097/qad.0000000000001488 · DOI
- Wu, 2017, Nucleoside reverse transcriptase inhibitors (NRTIs) induce proinflammatory cytokines in the CNS via Wnt5a signaling, Sci Rep, 7, 4117, 10.1038/s41598-017-03446-w · DOI
- Yu, 2018, Combining new non-nucleoside reverse transcriptase inhibitors (RTIs) with AZT results in strong synergism against multi-RTI-resistant HIV-1 strains, Molecules, 23, 10.3390/molecules23071599 · doi:10.3390/molecules23071599
- Yang, 2018, Quercetin attenuates AZT-induced neuroinflammation in the CNS, Sci Rep, 8, 6194, 10.1038/s41598-018-24618-2 · DOI
- Sörstedt, 2018, Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI mutations, Int J Antimicrob Agents, 51, 10.1016/j.ijantimicag.2018.01.009 · DOI
200 of 247 shown
Cited by
Santerre, M., Shcherbik, N., & Sawaya, B. E. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04255-4
Metadata
- Authors
- Zaongo, S. D., Wu, W., & Chen, Y.
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2025-04-17
- Volume
- 16
- ISSN
- 1664-0640
- Cited by
- 5
- References
- 32
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pathogenesis of HIV-associated depression: contributing factors and underlying mechanisms. https://app.cochat.ai/papers/10.3389/fpsyt.2025.1557816
- The paper
- Zaongo, S. D., Wu, W., & Chen, Y. (2025). Pathogenesis of HIV-associated depression: contributing factors and underlying mechanisms. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2025.1557816
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.